Austin, Texas – November 10, 2026 -- Shokz's OpenHear BM420, a bone conduction hearing aid that leaves the ear canal open, goes on sale in the U.S. on November 20, 2026, after being named a CES 2027 Innovation Awards Honoree in the Accessibility & Longevity category.
The BM420 is a non-surgical alternative to in-ear and implanted devices
Developed by ShokzHear, Shokz's affiliated hearing-care company, the BM420 is professionally fitted. It is designed as an alternative to traditional in-ear hearing aids and to implantable bone conduction solutions. Because the ear canal stays unobstructed, the device is meant to be comfortable during extended wear.
Hearing settings are individually adjustable. Directional microphones and background noise reduction are built in to improve speech clarity in everyday environments.
ShokzHear Director Fengyun Liao said performance matters in hearing care, but so does whether people are comfortable wearing a device "day after day."
Patients can get it through hearing centers, ENT clinics and hospitals
The BM420 will be available from November 20, 2026, through participating hearing centers, ENT clinics and hospitals in the U.S.
Shokz will show more open-ear technology at CES 2027 in Las Vegas
Shokz plans to exhibit at CES 2027, which runs January 6-9, 2027, in Las Vegas. The company says it will present open-ear technology applications that go beyond traditional audio.
The CES Innovation Awards are owned and produced by the Consumer Technology Association. A panel of engineers, designers and media members evaluates entries. The CTA states that the awards are based on descriptive materials submitted to the judges, and that it did not verify any submission's claims or test the products.